Toll-like receptor 4 in COVID-19: friend or foe?

被引：37
|
作者：
Mukherjee, Suprabhat [1 ]
机构：
[1] Kazi Nazrul Univ, Dept Anim Sci, Integrat Biochem & Immunol Lab, Asansol 713340, W Bengal, India
来源：
FUTURE VIROLOGY | 2022年 / 17卷 / 07期
关键词：
COVID-19; cytokine storm; immunotherapy; SARS-CoV-2; TLR4; TLR4;
D O I：
10.2217/fvl-2021-0249
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Tweetable abstract Toll-like receptor 4, an innate immune sensor, is one of the key 'fate-deciding' regulators of immunity as well as COVID-19 immunopathogenesis. Suitable targeting of Toll-like receptor 4 appears to be an effective strategy to counteract the pandemic.
引用
收藏
页码：415 / 417
页数：3
相关论文
共 50 条
  • [21] Epinephrine use in COVID-19: friend or foe?
    Luo, Pan
    Liu, Dong
    Li, Juan
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (01)
  • [22] The immune system and COVID-19: Friend or foe?
    Yazdanpanah, Fereshteh
    Hamblin, Michael R.
    Rezaei, Nima
    LIFE SCIENCES, 2020, 256
  • [23] Supplemental oxygen in COVID-19: a friend or foe?
    Yilmaz, Ozgur
    Yilmaz, Evrim
    CLINICAL MEDICINE, 2020, 20 (05) : E137 - E137
  • [24] The investigation of host genetic variants of toll-like receptor 7 and 8 in COVID-19
    Bagci, Gokhan
    Gundogdu, Oguz
    Pektas, Ayse Nur
    Bagci, Binnur
    Avci, Onur
    Gursoy, Sinan
    Kaygusuz, Kenan
    Elaldi, Nazif
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2023, 42 (08): : 586 - 602
  • [25] Combinations of alum and synthetic toll-like receptor agonists as adjuvants for CoVID-19 vaccines
    Davison, Clara J.
    Partlow, Haley A.
    Lathrop, Stephanie K.
    Siram, Karthik
    Abdelwahab, Walid
    Burkhart, David J.
    Evans, Jay
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [26] Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?
    Badagliacca, Roberto
    Sciomer, Susanna
    Petrosillo, Nicola
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (07): : 729 - 730
  • [27] Coagulation Disorders in COVID-19: Role of Toll-like Receptors
    Biswas, Indranil
    Khan, Gausal A.
    JOURNAL OF INFLAMMATION RESEARCH, 2020, 13 : 823 - 828
  • [28] Toll-like receptors polymorphisms and COVID-19: a systematic review
    dos Santos, Barbara Rayssa Correia
    dos Santos, Luana Karen Correia
    Ferreira, Jean Moises
    dos Santos, Ana Caroline Melo
    Sortica, Vinicius Albuquerque
    Figueiredo, Elaine Virginia Martins de Souza
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024,
  • [29] Toll-like receptor 2 and toll-like receptor 4 expression in human adrenals
    Bornstein, SR
    Schumann, RR
    Rettori, V
    McCann, SM
    Zacharowski, K
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (07) : 470 - 473
  • [30] Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant
    Abhyankar, Mayuresh M.
    Mann, Barbara J.
    Sturek, Jeffrey M.
    Brovero, Savannah
    Moreau, G. Brett
    Sengar, Anjali
    Richardson, Crystal M.
    Agah, Sayeh
    Pomes, Anna
    Kasson, Peter M.
    Tomai, Mark A.
    Fox, Christopher B.
    Petri, William A., Jr.
    NPJ VACCINES, 2021, 6 (01)
12345